TARS FY 2019 Earnings — Tarsus Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

TARSTarsus Pharmaceuticals, Inc.

$3B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$74,000

Operating Income

-$4M

Net Income

-$5M

EPS (Diluted)

$-0.24

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$18,000

Balance Sheet

Total Assets

$58M

Total Liabilities

$64M

Stockholders' Equity

-$6M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$74,000	-$1,000	-7300.0%
Operating Income	-$4M	-$1M	-218.4%
Net Income	-$5M	-$1M	-254.1%